A Manchester BRC-funded study has shown that a simple system, called the Manchester Score, can identify more breast cancer patients who are eligible for testing for inherited faulty genes that can cause breast cancer.
Women treated for ovarian cancer caused by an inherited faulty gene have a lower risk of developing breast cancer following that treatment, new research from Manchester University NHS Foundation Trust supported by Manchester BRC has revealed.
Researchers are trying to reduce the risk of cancer and improve diagnosis, treatments, and survivorship through our Cancer Cluster. Find out more about the range and impact of our cutting-edge research in the third film of our Spotlight On series.
Two Manchester BRC supported research teams have been recognised at The University of Manchester's Making a Difference Awards.
A groundbreaking cancer research project launched in memory of the late Girls Aloud singer Sarah Harding, is already successfully identifying young women at increased risk of breast cancer after just one year of opening.
The 'Team Womb' collective based at Manchester University NHS Foundation Trust and The University of Manchester, supported by the NIHR Manchester Biomedical Research Centre, have been awarded a prestigious American Association for Cancer Research Award.
Manchester researchers have developed a way to improve the accuracy of breast cancer genetic testing for women from Ashkenazi Jewish backgrounds.
A pioneering cancer research project launched in memory of singer Sarah Harding, and made possible through funding from The Christie Charity Sarah Harding Breast Cancer Appeal and Cancer Research UK, has recruited its first participant.